Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal Thoughts




Ozempic is under review by European drug-safety regulators after they received reports of suicidal thoughts linked to the popular weight-loss drug and another medicine in the class.




Ozempic is under review by European drug-safety regulators after they received reports of suicidal thoughts linked to the popular weight-loss drug and another medicine in the class.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@technoblender.com. The content will be deleted within 24 hours.
Adverse Drug Reactionsbusiness newsC&E Industry News FilterCommunityContent TypescorporateCorporate/Industrial NewsDK:NOVO.BEarningsEuropeFactiva FiltersFinancial Performancegeneral newsgovernment policyHealthhealthcareHealthcare/Life Sciencesindustrial newsLatestlife scienceslifestylelivingLiving/LifestyleMarketmental fitnessNovo NordiskNovo Nordisk A/S Series BNOVO-B.KOOzempicPharmaceuticalsPhysicalPhysical/Mental FitnesspoliticalPolitical/General NewsProbingRaisesregulationRegulation/Government PolicyriskSocial issuessocietySociety/CommunitysuicidalSuicideSYNDThoughtsWeight ManagementWSJ-PRO-WSJ.comwsjhealth
Comments (0)
Add Comment